Danyelza
Product Images NDC 73042-201

1 FDA label image from Y-mabs Therapeutics, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Danyelza (NDC 73042-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Y-mabs Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Principal Display Panel (40 mg/10 mL Vial Carton)

Principal Display Panel (40 mg/10 mL Vial Carton)
The packaging label for DANYELZA (naxitamab-gqgk) Injection, 40 mg/10 mL (4 mg/mL), features a single-dose vial intended for intravenous infusion after dilution. The label includes manufacturer information for Y-mAbs Therapeutics, Inc. and storage instructions to keep refrigerated at 2°C to 8°C (36°F to 46°F). It notes no preservative and advises discarding any unused portion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.